✦ LIBER ✦

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

✍ Scribed by Burger, J. A.; Ghia, P.; Rosenwald, A.; Caligaris-Cappio, F.

Book ID: 118246589
Publisher: American Society of Hematology
Year: 2009
Tongue: English
Weight: 516 KB
Volume: 114
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2009-06-225326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

97 INVITED The Microenvironment in B Cel

97 INVITED The Microenvironment in B Cell Malignancies – a New Target for Therapy?

✍ P. Ghia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Deoxycoformycin in the treatment of matu

Deoxycoformycin in the treatment of mature B-cell malignancies

✍ Dearden, C; Catovsky, D 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 430 KB

New strategies for targeting the hypoxic

New strategies for targeting the hypoxic tumour microenvironment in breast cancer

✍ Carol Ward; Simon P. Langdon; Peter Mullen; Adrian L. Harris; David J. Harrison; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 450 KB

TCL1: a new drug target in lymphoid and

TCL1: a new drug target in lymphoid and germ-cell malignancies?

✍ Richard B. Lock 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Interactions between tumor cells and mic

Interactions between tumor cells and microenvironment in breast cancer: A new opportunity for targeted therapy

✍ Shreya Mitra; Katherine Stemke-Hale; Gordon B. Mills; Sofie Claerhout 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Cancer stem cells in prostate adenocarci

Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies

✍ D. Fioriti; M. Mischitelli; F. Di Monaco; F. Di Silverio; E. Petrangeli; G. Russ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract Prostate cancer (PC) is major common malignancy in males in most industrialized Western countries, where it is the most commonly diagnosed cancer affecting men after middle age (>50 years). Over 90% of PC patients with incurable disease respond to primary treatment, which consists of in